Membership in the Good CME Practice Group illustrates the Kenes commitment to high standards and knowledgeable partnership with its clients in the design and delivery of educationally strong, independent, transparent, effective and financially viable medical events.
After participating in this educational event, learners should be able to:
- Address individual needs in compliance with their Continuous Professional Development (CPD) plan.
- Identify the clonal architecture of MDS, as demonstrated by recent high-throughput gene sequencing techniques.
- Describe recent research on spliceosome mutations, the most common class of somatic mutation in MDS.
- Identify mechanisms by which the epigenome in MDS is altered including what genes important in transcriptional regulation are commonly mutated.
- Utilise newer prognostic systems such as the Revised International Prognostic Scoring System.
- Discuss new clinical trial designs to expedite evaluation of promising new therapies for MDS.
- Integrate new knowledge of stem cell renewal and stem cell biology into the management of MDS patients.
- Manage patients with therapy-related MDS/AML (t-MDS/AML).
- Identify best practices for disease modifying drug interventions for myelodysplastic syndromes.
- Discuss recent technical, clinical, and basic research with potential to improve patient care and outcomes.
- Evaluate evolving methods for MDS diagnosis, including flow cytometry and molecular profiling.
- Provide expert guidance and explain available web-based tools for patients with MDS.
- Discuss and strength the relevant role of nurses in the care of MDS patients.
- Identify relevant health economics and outcomes research (especially those patient-centered) influencing care of patients with MDS nowadays and in short-term future.
MDS 2017 designed to meet the educational needs of physicians, nurses, pharmacists, social workers and psychologists involved in the care of patients with cancer: Haematology, Paediatrics, Medical Oncology, Oncology Nursing and Surgical Oncology. Because of the diverse, clinically focused educational offering, participants are able to tailor the curriculum to meet the needs of international clinicians of all levels of experience.
ACCREDITATION STATEMENT AND CREDIT DESIGNATION European Accreditation Council for Continuing Medical Education (UEMS/EACCME)
The 14th International Symposium on Myelodysplasic Syndromes is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS): www.uems.net
The 14th International Symposium on Myelodysplasic Syndromes is designated for a maximum of, or up to, 18 European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
American Medical Association (AMA)
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.
Royal College of Physicians and Surgeons of Canada
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: www.royalcollege.ca.
UEMS/EACCME Credit Breakdown
Each participant should claim only those hours of credit that he/she actually spent in the educational activity.
|Wednesday, May 3, 2017||3|
|Thursday, May 4, 2017||6|
|Friday, May 5, 2017||6|
|Saturday, May 6, 2017||3|
ACCREDITATION STATEMENT AND CREDIT DESIGNATION
European Hematology Association (EHA)
The European Board for Accreditation in Hematology (EBAH) has approved this educational activity for a maximum number of 20 CME credits. Each physician should only collect credits for time that she/he actually spent in the educational activity.
To Receive Your CME/CPD Certificate
The CME/CPD certificate will be available after completing the online evaluation and credit claiming procedure. The process takes about 5 minutes. We thank you for your feedback as it is an important part of CME/CPD accreditation and helps improve future educational offerings.
Before June 3, 2017:
1. Access the online system via any of the following
- Visit the following link
- Please note that web browsers Mozilla Firefox 2.X or higher, or Google Chrome are recommended
- Visit the CME/CPD Accreditation page on the event website
- Follow the link in the email sent at the end of the event
2. Complete the anonymous online evaluation
3. Complete the credit claim form and submit
4. The CME/CPD certificate will be available for download; fill-in and retain for your personal records
Kindly note that the MDS 2017 online evaluation will be active on the last day of the meeting. You will then be able to access it and claim your CME/CPD certificate.
Disclosure and Resolution of Personal Conflicts of Interest
In accordance with CME/CPD accreditation criteria and standards for commercial support to ensure balance, independence, objectivity, and scientific rigor, those in control of the educational content must disclose potential or actual conflicts of interest. Disclosure information is evaluated and conflicts of interest resolved. Disclosure is made to participants prior to the activity. Participants will be asked on the evaluation to assess the objectivity and independence of the event.
- Disclosure information will be available here at least one week prior to the event.